Znn3bq.jpeg
²é¿´: 1382  |  »Ø¸´: 1

fuanxitan

Ìú³æ (СÓÐÃûÆø)

[½»Á÷] BioTechniques£º2015×îÊÜ»¶Ó­µÄ¼¼ÊõÎÄÕ ÒÑÓÐ1È˲ÎÓë

1. Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes

ÎÒÃǶ¼ÔøÔÚ»¯Ñ§¿ÎÉϸù¾ÝpHÊÔÖ½µÄÑÕÉ«ÅжϹýÈÜÒºµÄËá¼î¶È¡£NEB¹«Ë¾µÄÑо¿ÍŶÓÒÔͬÑùµÄÀíÄ»ùÓÚpHÖµµÄÑÕÉ«¸Ä±ä£©Îª»ù´¡£¬¿ª·¢ÁËÒ»ÖÖ¶ÔpHÃô¸ÐµÄ±äɫȾÁÏ£¬¸øDNAÀ©Ôö¸³ÓèÁËÈâÑۿɼûµÄÑÕÉ«¸Ä±ä¡£ÕâÒ»¼¼Êõ¿ÉÒÔ°ïÖúÈËÃÇÖ±½ÓÓÃÑÛ¾¦ÅжϺËËáÀ©ÔöµÄ½á¹û£¬²»ÐèÒª½èÖúÈκÎÌØÊâÉ豸£¬ÔÚÒ°ÍâÑо¿¡¢Ìï¼äÊÔÑé¡¢ÁÙ´²Õï¶ÏµÈÁìÓòÓÐ׏ãÀ«µÄÓ¦ÓÃǰ¾°¡£

2. A single protocol for extraction of gDNA from bacteria and yeast

Ðí¶à·Ö×ÓÉúÎïѧ¼¼Êõ¶¼ÔÚ±»ÈËÃDz»¶ÏÓÅ»¯£¬±ÈÈçPCR¡¢ÖÊÆ×ºÍ²âÐò¡£È»¶ø£¬DNAÌáÈ¡·½·¨È´Ê¼ÖÕûÓÐʲô̫´óµÄ¸Ä±ä¡£

ÕâÏîÑо¿ÎªÈËÃÇչʾÁËÒ»ÖÖеÄDNAÌáÈ¡·½·¨¡£Ñо¿ÏÔʾ£¬¼ÓÈÈÒÒ´¼¼îÐÔÈÜÒº£¬ÄÜÒÔÏàËÆµÄЧÂÊÊͷųöϸ¾úºÍ½ÍĸÖеĵ¥Á´DNA¡£ÀëÐÄËùµÃµÄDNA¿ÉÒÔÖ±½ÓʹÓã¬Ò²¿ÉÒÔÌí¼Óµ½¹è½ºÖù½øÒ»²½´¿»¯¡£ÕâÖÖ¿ìËÙ¡¢¾­¼Ã¶øÇÒ¿É¿¿µÄ·½·¨ÓÐÖúÓÚ¼ø¶¨Î´ÖªµÄ΢ÉúÎËü²»»áºöÊÓ»òÆ«ÏòÌØ¶¨Î¢ÉúÎï¡£ÕâÖÖDNAÌáÈ¡·½·¨ÄÜÔÚ25·ÖÖÓÄÚ´¦Àí¸÷ÖÖÉúÎïÑùÆ·£¬¿ÉÒÔÓÃÓÚÁÙ´²Õï¶Ï»òÕßÉúÎïҽѧÑо¿¡££¨Ïà¹Ø±¨µÀ£ºBioTechniques£º´Óϸ¾úºÍ½ÍĸÖÐÌáÈ¡gDNAµÄ¼ò±ã·½·¨£©

3. Affinity proteomics to study endogenous protein complexes: Pointers, pitfalls, preferences and perspectives

µ°°×³£³£Í¨¹ýÏ໥×÷ÓÃÀ´Ö´ÐÐϸ°û¹¦ÄÜ£¬ÌØÒìÐÔ·ÖÀëµ°°×¼°Æä»¥×÷´îµµ£¬¶ÔÓÚ½âÎöϸ°ûÌåϵºÜÓаïÖú¡£Ç׺Ͳ¶»ñ¼¼ÊõÀûÓøßÇ׺ÍÁ¦¡¢¸ßÌØÒìÐÔµÄÊÔ¼Á£¬ÔÚϸ°ûÌáÈ¡ÎïÖв¶×½Ä¿µÄµ°°×¼°ÆäÏà¹Øµ°°×¡£½«Ç׺Ͳ¶»ñÓëÖÊÆ×½áºÏÆðÀ´½øÐе°°×ÖÊ×é·ÖÎö£¬¿ÉÒÔ·ÖÀëºÍ¼ø¶¨´óÁ¿µÄÄÚÔ´ÐÔµ°°×¸´ºÏÌå¡£ÕâÆªÎÄÕ²ûÊöÁËÇ׺Ͳ¶»ñµ°°×¸´ºÏÌåµÄÓÐЧ²½Ö裬̽ÌÖÁ˽øÐÐÕâÀàʵÑéµÄ×î¼Ñ·½·¨ºÍһЩ³£¼ûÎóÇø¡£

4. CRISPR/Cas9 nuclease cleavage combined with Gibson assembly for seamless cloning

CRISPR-Cas9ÊÇϸ¾úÔÚÂþ³¤µÄ½ø»¯Ê·ÖÐÑÝ»¯³öµÄÖØÒª·ÀÓù»úÖÆ¡£Õâ¸ö¼à¿ØÌåϵÄܹ»¸ù¾ÝÒýµ¼RNAµÄָʾ£¬°Ð±ê²¢½µ½âÈëÇÖÕßµÄÒÅ´«ÎïÖÊ¡£ÏÖÔÚ£¬CRISPR-Cas9ÒѾ­³ÉΪÁËÖËÊÖ¿ÉÈȵĻùÒò×é±à¼­¹¤¾ß£¬°ïÖúÊÀ½ç¸÷µØµÄÑо¿ÕßÃǽâ¾öʵ¼ÊÎÊÌâ¡£

¿Ë¡ÊÇ»ùÒò¹¤³ÌµÄÒ»¸ö»ù±¾¹¤¾ß£¬ÕâÏîÑо¿½«CRISPR¨CCas9ÓëGibson assembly½áºÏÆðÀ´£¬¿ª·¢ÁËÒ»ÖÖ¿ìËÙÓÐЧµÄÎÞ·ì¿Ë¡¼¼Êõ¡£Ñо¿ÈËԱʹÓÃÒ»¸öT7ת¼ģ°åÀ´Éú³ÉÒýµ¼RNA£¨sgRNA£©£¬°Ð±ê¿ËÂ¡ÔØÌåÉϵÄÌØ¶¨Î»µã¡£ËûÃÇÓÃÕâÖÖsgRNAºÍCas9ÇпªÁËÒ»¸ö22 kbµÄÔØÌ壬²¢Í¨¹ýGibson assemblyÔÚÆäÖвåÈëÒ»¶ÎDNA¡£Ñо¿±íÃ÷£¬ÕâÊÇÒ»¸öÄܹ»ÊµÏÖÎÞ·ì¿Ë¡µÄÇ¿´ó¹¤¾ß£¬¿É½«DNAƬ¶ÎÖ±½Ó²åÈëÔØÌåÉϵİÐλµã¡£

5. Preparation of amino acid mixtures for cell-free expression systems

ÕâÆªÎÄÕÂÃèÊöÁËÒ»¸öΪÎÞϸ°ûµ°°×±í´ïÌåÏµÖÆ±¸¸ßŨ¶È°±»ùËá»ìºÏÎïµÄÓÐЧ·½·¨¡£Ñо¿ÈËԱͨ¹ýÕâÒ»·½·¨»ñµÃÁËÀíÏëµÄ°±»ùËá×é³ÉºÍÉúÀíÐÔpH¡£ÕâÖÖ·½·¨Ëٶȿ죬ÈÝÒײÙ×÷£¬Ò²±ÈÉÌÒµ»¯ÊÔ¼ÁºÐ±ãÒË¡£ÈËÃÇ¿ÉÒÔÔÚ´Ë»ù´¡ÉϽøÐиßͨÁ¿ÊµÑé¡¢ÎÞϸ°û´úл¹¤³Ì»òÕß²ôÈë·Ç±ê×¼°±»ùËá¡£

6. Micropatterning strategies to engineer controlled cell and tissue architecture in vitro

΢ͼ°¸»¯¼¼Êõ£¨Micropatterning£©¿ÉÔÚÌåÍâ¿ØÖÆÏ¸°ûºÍ×éÖ¯µÄ¹¹¼Ü£¬ÊÇÄ£Äâ×é֯΢»·¾³µÄʵÓÃÆ½Ì¨¡£ÕâÆª×ÛÊöÎÄÕ½éÉÜÁËһЩ³£ÓõÄ΢ͼ°¸»¯¼¼Êõ£¬¿ÉÒÔÒýµ¼ÐÂÊÖÕÒµ½ÊʺÏ×Ô¼ºµÄ·½·¨£¬°ïÖúËûÃÇ»ñµÃ×Ô¼ºÏëÒªµÄ×é֯ģʽ¡£ÎÄÕ»¹Ì½ÌÖÁË΢ͼ°¸»¯¼¼ÊõĿǰËùÃæÁÙµÄһЩ¹Ø¼üÐÔÌôÕ½¡£

7. Simultaneous isolation of enriched myoblasts and fibroblasts for migration analysis within a novel co-culture assay

ÕâÒ»¼¼Êõ¿ÉÒÔ°ïÖúÈËÃÇÔÚ½ºÔ­Ã¸Ïû»¯Ö®ºó£¬Í¬Ê±·ÖÀëºÍ¸»¼¯³ÉÏËάϸ°ûºÍ³É¼¡Ï¸°û¡£ÕâЩϸ°ûËæºó¿ÉÓÃÓÚÒ»¸ö¹²ÅàÑøµÄ´´ÉËÐÞ¸´ÏµÍ³£¬ÎªÈËÃǽÒʾ³ÉÏËάϸ°û¶Ô³É¼¡Ï¸°ûÇ¨ÒÆµÄÓ°Ïì¡£

8. High-throughput detection of DNA double-strand breaks using image cytometry

ÕâÏîÑо¿ÎªÈËÃÇչʾÁËÒ»¸ö¸ßͨÁ¿µÄ·½·¨£¬ÓÃͼÏñϸ°û·ÖÎö¼¼Êõ£¨image cytometry£©¿Í¹ÛµØÑо¿DNAË«Á´¶ÏÁѵÄϸ°ûÐÞ¸´»úÖÆ¡£

9. Abridged adapter primers increase the target scope of Hi-Plex

Hi-PlexÊÇÒ»ÖÖÒÔÀ©Ôö×ÓΪ»ù´¡µÄ°ÐÏòÐÔ´ó¹æÄ£Æ½ÐвâÐò¼¼Êõ¡£Ñо¿ÈËÔ±¶ÔHi-Plex·½·¨½øÐÐÁ˸ÄÁ¼£¬Ê¹Æä¿ÉÒ԰бê¸ü¶àµÄÀ©Ôö×Ó£¨16¨C1003£©¡£ËûÃÇ»¹Óýض̵ĽÓÍ·ÒýÎïÀ´Ìæ´úÈ«³¤µÄ½ÓÍ·ÒýÎ³É¹¦¼õÉÙÁË֮ǰµÄÍѰÐЧӦ¡£

10. Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection

ÕâÏîÑо¿½«»ùÓÚhybcellµÄ²âÐò¼¼ÊõÓÃÓÚKRASÍ»±ä·ÖÎö£¬²¢½«ÕâÖÖ·½·¨ÓëSanger²âÐò¡¢½¹Á×Ëá²âÐòºÍ¶þ´ú²âÐò½øÐÐÁ˱Ƚϡ£Ñо¿Ö¸³ö£¬ÒÔhybcellΪ»ù´¡µÄ²âÐò¼¼ÊõºÜÊʺÏÔÚÖ×ÁöÑù±¾Öмì²âKRASµãÍ»±ä¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liu_yanpeng

Ìú¸Ëľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÇëÎÊÏà¹ØÎÄÕÂÔÚÄÄ
2Â¥2016-01-29 13:30:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ fuanxitan µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 300Çóµ÷¼Á +8 ³Èa777 2026-04-15 8/400 2026-04-16 01:25 by L0alice
[¿¼ÑÐ] 291 Çóµ÷¼Á +40 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 41/2050 2026-04-15 21:54 by noqvsozv
[¿¼ÑÐ] 22408 312Çóµ÷¼Á +20 ÃÅ·ÃþÃþ 2026-04-14 21/1050 2026-04-15 20:39 by cuisz
[¿¼ÑÐ] 297¹¤¿Æµ÷¼Á? +14 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-13 15/750 2026-04-15 13:25 by ºÚ¿Æ¼¼¿óÒµ
[¿¼ÑÐ] 279Çóµ÷¼Á +12 ÕÅ·¬ÇѲ»³´µ° 2026-04-11 12/600 2026-04-14 15:38 by zs92450
[¿¼ÑÐ] 271Çóµ÷¼Á +35 2261744733 2026-04-11 41/2050 2026-04-14 15:36 by zs92450
[¿¼ÑÐ] 302Çóµ÷¼Á +10 Ò×£¡? 2026-04-13 10/500 2026-04-13 19:04 by lbsjt
[¿¼ÑÐ] һ־Ը˫·Ç085400µç×ÓÐÅÏ¢344 Çóµ÷¼Á£¬¶Ô²ÄÁϺͻ¯Ñ§·½ÏòÒ²¸ÐÐËȤ +12 ÎÞÇéµÄСÑò 2026-04-09 13/650 2026-04-13 14:17 by ÕÅzhihao
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á +11 СȽҪŬÁ¦ 2026-04-10 13/650 2026-04-13 11:46 by µç»¯Ñ§¼°´ß»¯
[¿¼ÑÐ] 0854µ÷¼Á +10 ³¤¹­°Á 2026-04-11 11/550 2026-04-13 10:38 by wp06
[ÕÒ¹¤×÷] ɽ¶«¸ßУ½Ìʦ¿¼ºË³¬¼¶ÎÞµ×Ïߣ¬Ô±¹¤¹ý²»ÏÂÈ¥À² +4 qut2026 2026-04-09 9/450 2026-04-12 00:54 by qut2026
[¿¼ÑÐ] 303Çóµ÷¼Á +14 SereinQ 2026-04-10 15/750 2026-04-11 20:43 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 284Çóµ÷¼Á +11 archer.. 2026-04-09 12/600 2026-04-11 20:23 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µ÷¼Á +5 ÎĵÀÐÇ̨ 2026-04-11 5/250 2026-04-11 15:01 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] 0854µ÷¼Á +4 ³¤¹­°Á 2026-04-09 4/200 2026-04-11 09:18 by Öí»á·É
[¿¼ÑÐ] µ÷¼Á +12 ¾í¾í¾íÐIJË_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[¿¼ÑÐ] µ÷¼Á +19 СÕÅZA 2026-04-10 20/1000 2026-04-10 22:08 by Öí»á·É
[¿¼ÑÐ] 298Çóµ÷¼Á +13 ¶¤¶£ß˶¬¹Ï 2026-04-09 13/650 2026-04-10 15:49 by jiajinhpu
[¿¼ÑÐ] 301Çóµ÷¼Á +5 149. 2026-04-10 5/250 2026-04-10 15:45 by ²ñС°×
[¿¼ÑÐ] 344Çóµ÷¼Á +7 ؼ·çѩҹ¹éÈËØ¼ 2026-04-09 7/350 2026-04-10 12:05 by pengliang8036
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û